BROWNIE: Metabolic Effects of Short Term Sugarcane Bagasse Supplementation

Sponsor
Pennington Biomedical Research Center (Other)
Overall Status
Completed
CT.gov ID
NCT01830686
Collaborator
(none)
23
1
3
20
1.1

Study Details

Study Description

Brief Summary

The purpose of this study is to help understand the benefits of eating food supplemented with fiber in the form of sugarcane bagasse (the leftover fiber after cane juice is extracted) on glucose metabolism and body weight.

Condition or Disease Intervention/Treatment Phase
  • Other: Sugarcane bagasse
  • Other: Non-caloric, non-fermentable fiber
  • Other: Minimal fiber
N/A

Detailed Description

The investigators will employ a double-blind randomized controlled study design with 3 arms such that obese, insulin resistant adults will be randomly selected to receive food made with

  1. sugarcane bagasse, 2) non-caloric, non-fermentable fiber, or 3) a similar product with minimal fiber for 4 weeks. The intervention will be in the form of brownies and cookies and will look and taste nearly identical to each other. Caloric value will be constant with all three delivery systems. Subjects will have blood testing and body composition analysis before and after the intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
23 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Official Title:
Metabolic Effects of Short Term Sugarcane Bagasse Supplementation
Study Start Date :
Apr 1, 2013
Actual Primary Completion Date :
Jan 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sugarcane bagasse

10 subjects will consume food (brownies and cookies) made with 13 g of sugarcane bagasse everyday for 4 weeks

Other: Sugarcane bagasse
One brownie containing 10 g of sugarcane bagasse and 2 cookies containing 3 g of sugarcane bagasse (total of 13 g of sugarcane bagasse per day)

Active Comparator: Non-caloric, non-fermentable fiber

10 subjects will consume food (brownies and cookies) made with 13 g of non caloric, non-fermentable fiber everyday for 4 weeks

Other: Non-caloric, non-fermentable fiber
One brownie containing 10 g of fiber and 2 cookies containing 3 g of fiber (total of 13 g of non-caloric, non-fermentable fiber per day)

Placebo Comparator: Minimal fiber

10 subjects will consume food (brownies and cookies) made with 4 g of dietary fiber everyday for 4 weeks

Other: Minimal fiber
One brownie containing 3g of fiber and two cookies containing 1g of fiber (total of 4 g of dietary fiber per day)

Outcome Measures

Primary Outcome Measures

  1. The benefit of sugarcane bagasse on glucose tolerance and insulin resistance in adults with established insulin resistance [4 weeks]

    Participants will be randomly selected to eat food supplemented with either 1) sugarcane bagasse, 2) another type of fiber of equal weight, or 3) minimal fiber. At baseline each eligible subject will have a 3 hour oral glucose tolerance test. Subjects will consume one brownie and two cookies a day for four weeks. At the end of four weeks, the blood tests conducted at baseline will be repeated.

Secondary Outcome Measures

  1. The effect of sugarcane bagasse on body weight/composition [4 weeks]

    At baseline and weekly till the end of the study, weight will be measured. In addition body composition via DXA will be measured at baseline and at the end of the study.

Other Outcome Measures

  1. The effect of sugarcane bagasse on incretin profiles as a mechanism to explain its metabolic effects [4 Weeks]

    At baseline and at the end of the study, glucagon-like peptide-1 and ghrelin levels will be measured.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males and females age 18-50 years

  • Body Mass Index ≥ 30 kg/m2 (a ratio of weight to height)

  • Fasting insulin level >5 µIU/mL, as determined by tests performed during screening

Exclusion Criteria:
  • Women who are pregnant

  • Past medical history of diabetes

  • History of intestinal surgery such as removal of bowel

  • History of problems with absorbing food such as celiac disease, inflammatory bowel disease, malabsorption syndrome

  • Taking chronic medications for any medical conditions such as diabetes, hypertension, cholesterol, thyroid hormone, etc.

  • Any food allergies

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pennington Biomedical Research Center Baton Rouge Louisiana United States 70808

Sponsors and Collaborators

  • Pennington Biomedical Research Center

Investigators

  • Principal Investigator: Daniel Hsia, MD, Pennington Biomedical Research Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Daniel Hsia, Principal Investigator, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier:
NCT01830686
Other Study ID Numbers:
  • PBRC 13005
First Posted:
Apr 12, 2013
Last Update Posted:
Feb 3, 2016
Last Verified:
Feb 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Daniel Hsia, Principal Investigator, Pennington Biomedical Research Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2016